The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Varvaro Thomas C since 2011.
The trader's CIK number is 1437495.
At the time of the last reporting, Varvaro Thomas C was the CFO, TREASURER AND SECRETARY of Mabvax Therapeutics Holdings, Inc.. (stock ticker symbol MBVX).
Also see all insider trading activities at Mabvax Therapeutics Holdings, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | MBVX | 0 | $0 | 35,441 | $30,293 | 100,513 | $0 |
2017 | MBVX | 0 | $0 | 0 | $0 | 1,543 | $0 |
2016 | MBVX | 0 | $0 | 0 | $0 | 11,417 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2014 | CDXC.OB | 3,500 | $3,952 | 0 | $0 | 0 | $0 |
2011 | CDXC.OB | 3,500 | $2,245 | 0 | $0 | 0 | $0 |
1. Mabvax Therapeutics Holdings, Inc. (MBVX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-04-03 | MBVX | Option Ex | 513 | .00 | 0 |
2018-01-23 | MBVX | Sale | 17,445 | .87 | 15,177 |
2018-01-24 | MBVX | Sale | 17,996 | .84 | 15,116 |
2018-01-08 | MBVX | Option Ex | 100,000 | .00 | 0 |
2017-04-02 | MBVX | Option Ex | 1,543 | .00 | 0 |
2016-04-04 | MBVX | Option Ex | 11,417 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-08-25 | CDXC.OB | Buy | 2,250 | 1.09 | 2,452 |
2014-08-22 | CDXC.OB | Buy | 1,250 | 1.20 | 1,500 |
2011-12-09 | CDXC.OB | Buy | 2,000 | .65 | 1,300 |
2011-12-07 | CDXC.OB | Buy | 1,500 | .63 | 945 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Varvaro Thomas C (CFO, TREASURER AND SECRETARY of Mabvax Therapeutics Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.